Merck’s COVID pill shows lower efficacy in updated study
Drugmaker says final analysis of trial results showed molnupiravir showed 30 percent risk reduction.
Drugmaker says final analysis of trial results showed molnupiravir showed 30 percent risk reduction.
While thousands hit the big stores for Black Friday, local shop owners are hoping the crowds will turn out…
Stocks ended with scant gains after another wobbly day of trading on Wall Street Wednesday as the market Stocks…
As consumer prices surged 6.2 percent, some fashion categories are increasing at twice that rate.
GFL Environmental went public in early 2022, raising $2.2 billion in a U.S. IPO. The firm provides a range…
Update: Now matched at Amazon.As part of its Amazon to match again once stock returns. That’s down from the usual…
NEW YORK (AP) — Stocks are closing sharply lower on Wall Street Friday, after a coronavirus variant from South…
Stocks are closing sharply lower on Wall Street Friday, after a coronavirus variant from South Africa appeared to be…
NEW YORK, NY / ACCESSWIRE / November 26, 2021 / Bernstein Liebhard, a nationally acclaimed investor rights law firm,…
PDD earnings call for the period ending September 30, 2021.